Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Preclinical studies reveal potential of KX-01 for treatment of breast cancer

Jan. 4, 2010

Phase I results suggest ARRY-380 is well tolerated, active in breast cancer patients

Dec. 31, 2009

Synergistic growth inhibition seen with BEZ-235 and dual EGFR and HER-2/neu inhibitor

Dec. 31, 2009

Activity of nab-rapamycin against breast cancer xenografts enhanced by other agents

Dec. 31, 2009

Tetrathiomolybdate may reduce endothelial progenitor cells in breast cancer patients

Dec. 30, 2009

MVA-BN-HER2 well tolerated, active in phase I breast cancer studies

Dec. 30, 2009

Breast cancer growth inhibition seen with JMR-132 and tamoxifen

Dec. 30, 2009

BTC induces apoptosis in PKCalpha overexpressing breast cancer cells

Dec. 30, 2009

New data indicate ridaforolimus-trastuzumab beneficial in refractory metastatic breast cancer

Dec. 30, 2009

BSI-201 added to gemcitabine/carboplatin improves survival in metastatic TNBC

Dec. 29, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...